RxDoctor Payments Data

Andrew Powell, DPM

Foot & Ankle Surgery · St George, UTNPI 1861499568

Payments from drug & device makers

$469in general payments, 2019–2025

Across 8 payments — averaging $58.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stimwave Technologies Incorporated$310
  • Abbott$55
  • Smith+Nephew$44
  • Alfasigma USA, Inc.$24
  • Nevro Corp.$21
  • Esaote North America, Inc.$17

What the payments were for

  • Food & beverage$469100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stimwave Technologies Incorporated3$310
Abbott1$55
Smith+Nephew1$44
Alfasigma USA, Inc.1$24
Nevro Corp.1$21
Esaote North America, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$469 in reported general payments places this provider in the 10th percentile of 104 foot & ankle surgery providers in Utah.

See all foot & ankle surgery providers in Utah

Medicare billing

Part B allowed, 2024
$274,715
Medicare patients
634
Services billed
4,395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin224$2,631
Cephalexin39$602
Celecoxib39$545
Terbinafine Hcl24$535
Methylprednisolone49$379
Meloxicam78$332
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$172
SsdSilver Sulfadiazine13$126
Pregabalin13$116
Clindamycin Hcl12$110
Amitriptyline Hcl11$64

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in St George

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →